West Pharmaceutical Servi... (WST)
West Pharmaceutical Services Inc. (WST) Stock Price, Analysis & Data
| Bid | 282.46 |
| Market Cap | 24.59B |
| Revenue (ttm) | 3.33B |
| Net Income (ttm) | 564.9M |
| Beta | 1.14 |
| EPS (ttm) | 7.83 |
| PE Ratio (ttm) | 44.63 |
| Forward PE | 35.07 |
| P/B (ttm) | 8.23 |
| P/S (ttm) | 7.39 |
| Earnings Date | Oct 22, 2026 |
| Ask | 397 |
| Volume | 272,152 |
| Avg. Volume (20D) | 756,737 |
| Open | 344.44 |
| Previous Close | 346.16 |
| Day's Range | 343.52 - 349.53 |
| 52-Week Range | 223.83 - 386.00 |
| Analyst | Strong Buy |
| Price Target | 410 (17.34%) |
| Dividends | $0.88 (0.25%) |
| Ex-Dividend Date | Jul 29, 2026 |
About WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom so...
Financial Performance
In 2025, West Pharmaceutical Services's revenue was 3.07B, an increase of 6.25% compared to the previous year's 2.89B. Earnings were 493.7M, an increase of 0.2%.
Financial StatementsAnalyst Forecast
According to 15 analyst ratings, the average rating for WST stock is "Strong Buy". The 12-month stock price forecast is 410, which is upside of 17.34% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
